Stock Locations

New Jersey, USA
Czech Republic, EU
Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

219674-97-2Maribavir Impurity 7

● In Stock

Catalogue No.:	VE0028053
CAS No.:	219674-97-2
Mol. Formula:	C15H19Cl2N3O4
Mol. Weight:	376.24 g/mol

Request a quote

Add to RFQ list

Additional information on CAS 219674-97-2

Parent drug

Maribavir

IUPAC Name

(2R,3R,4R,5S)-2-(5,6-Dichloro-2-(isopropylamino)-1H-benzo[d]imidazol-1-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol

Pharmacopeial Synonyms

N/A

Synonyms

N/A

Smiles

CC(NC1=NC2=CC(Cl)=C(Cl)C=C2N1[C@H](O[C@H]3CO)[C@H](O)[C@H]3O)C

InChI

InChI=1S/C15H19Cl2N3O4/c1-6(2)18-15-19-9-3-7(16)8(17)4-10(9)20(15)14-13(23)12(22)11(5-21)24-14/h3-4,6,11-14,21-23H,5H2,1-2H3,(H,18,19)/t11-,12-,13+,14+/m0/s1

Description

Maribavir Impurity 7 (CAS 219674-97-2) is a process and degradation-related impurity arising within maribavir synthetic routes, characterized by a distinct chromatographic retention profile and a reproducible high resolution mass spectral fingerprint. Structural confirmation is supported by 1D and 2D NMR, LC-MS and UV absorbance data, revealing functional motifs closely related to the parent scaffold that can affect ionization and detectability. Its physicochemical behavior may complicate chromatographic separation and quantification, necessitating optimized method development and orthogonal analytical approaches. Comprehensive spectral documentation and batch-specific analytical data enable confident identification and trace-level monitoring.